Observational Follow-up Extension Study of AFF002 and AFF004A in Patients With Alzheimer's Disease

Terminated

• Conditions: Alzheimer´s Disease

• Registration Number: NCT01357629
• Lead Sponsor: Affiris AG

Brief Summary

This study examines the long term Safety Follow-up of first patients vaccinated with AD02.

Detailed Description

Patients who have received AD02 during AFF002 and AFF004A will be observed.

Study Timeline

• Study First Submitted: 2011-03-21
• Study First Submitted QC: 2011-05-20
• Study First Posted: 2011-05-23
• Study Start: 2011-07
• Primary Completion: 2013-04
• Study Completion: 2013-11
• Status Verified: 2013-12
• Last Update Submitted: 2013-12-10
• Last Update Posted: 2013-12-11

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 11

Inclusion Criteria

• participation in AFF002 and AFF004A

Exclusion Criteria

• no vaccination with AD02

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Safety	up to 2 years	collection and evaluation of AEs, SAEs

Trial Locations

Locations (2)

Studienzentrum der PROSENEX Ambulatoriumsbetriebs GmbH; 🇦🇹 Vienna, Austria

Univ. Klinik für Psychiatire und Psychotherapie; 🇦🇹 Wien, Austria